UPDATE! Is Someone Pumping Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN)?

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN)

UPDATE: After speaking with an executive at Diffusion Pharmaceuticals Inc., StockNewsUnion.com can confirm that a patent was formally issued to the biotech firm yesterday. HOWEVER, and this is important, the patent award was disclosed this past summer. So the financial impact of the patent issuance had already been “baked” into the share price of DFFN before yesterday’s trading when the patent “news” was revealed by a stock news service.

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) has been hit with massive volumes in mid-day trading sending DFFN shares up over 70%. Volumes began spiking around 11:19 AM EST. Trader chat rooms were abuzz on the stock’s activity in the absence of any news release from Diffusion. Rumors began circulating that a web service that caters to day-traders had published an announcement that Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) had been awarded a patent however no confirmation exists outside of that service. Curiously, many traders in the chat rooms who are claiming to be long shares of DFFN expressed glee at the plight of any short-sellers and speculated that DFFN shares would explode further to the upside once the short-sellers covered their positions. However the “short float” on DFFN shares is only 0.06%. It is also highly curious that a day-trading signal service would acquire knowledge of a patent award prior to the release of the news through the company’s official channels.

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ended yesterday at $2.74 and opened at that price. DFFN’s price held within a few pennies of $2.74 until 11:19 AM EST when volumes started picking up. Eleven minutes later, 11:30 AM EST, the inter-day high of $4.80 would be reached. From that point forward, DFFN shares began a slide and the stock is currently trading around $3.60 at 1:44 PM EST. Already volumes have reached 20 times their normal daily average.

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) is a nano-cap biotech with a market-cap of less than $30 million. A patent award would be huge for such a small company that has reported no sales since 2013 when it reported a figure of $100,000. EPS losses have been fairly heavy. On a diluted share basis EPS losses in 2011 were -$303.86. EPS losses continued each year since and in 2015 the EPS loss was -$12.80. Dilution has also been a nemesis of DFFN shareholders. In 2008, there were 80,000 shares outstanding. By 2015 there were 1.86 million.

Any readers with information on today’s price action surrounding Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) are urged to leave it in the comment box below.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

Gaming Company Everi Holdings Inc. (NYSE:EVRI) Hits 52-week Highs On Earnings Report

Everi Holdings Inc. (NYSE:EVRI)

Everi Holdings Inc. (NYSE:EVRI) supplies casinos with video and reel gaming content and technology, payment solutions, and compliance and efficiency software. Everi Holdings Inc. sells its products and services to casinos and other gaming properties in the United States, Europe, Canada, the Caribbean, Central America, and Asia. Everi, headquartered in Las Vegas, NV, was formerly known as Global Cash Access Holdings, Inc. and changed its name to Everi Holdings Inc. in August 2015.

Institutions own 69% of Everi Holdings Inc. (NYSE:EVRI). In the last year EVRI shares are up just 1.89 % (prior to today’s price action) but shares are up almost 50% YTD. EVRI shares are up over 240% from their 52-week lows and up over 12% from their previous 52-week highs. Today’s action was unusual. EVRI shares had an Average True Range (ATR) of only 0.14 but today the shares have a low of $3.51 and a high of $4.27. This is commensurate with the explosion in volumes. EVRI average daily volumes are listed at just under 316,000 but by 2 PM EST, over 2.9 million shares had traded hands.

For Q4 2016, Everi Holdings Inc. (NYSE:EVRI)posted revenues of $217.5 million which was up 6.4% YoY and beat estimates by $5.83 million. It did experience an EPS loss of -$3.29 for Q4. For 2016 EVRI reported a net loss of $249.5 million on revenues (vs. 2015 loss of $104.9 million) of $859.5 million (versus 2015 revenues of $827 million). 2016 adjusted EBITDA was 198.1 million versus 2015 adjusted EBITDA of $200.5 million.

In 2015 shareholders of Everi Holdings Inc. (NYSE:EVRI) experienced an EPS loss of -$1.59 compared to an EPS gain of $0.19 in 2014. However sales did improve. In 2014 sales were reported at $593.1 million and that figure improved to $827 million in 2015. Two firms follow Everi Holdings Inc. (NYSE:EVRI). One rates EVRI shares as a “Strong Buy” while the other rates the shares as a “Hold”. Their consensus price target is $3.75 – about where the stock now stands.

3/15/2017
Ticker Symbol EVRI
Last Price a/o 1:56 PM EST  $                      3.79
Average Volume                    315,750
Market Cap (mlns)  $                  216.04
Sales (mlns) $846.40
Shares Outstanding (mlns) 66.68
Share Float (mlns) 65.05
Shortable Yes
Optionable Yes
Inside Ownership 0.40%
Short Float 0.64%
Short Interest Ratio 1.31
Quarterly Return 36.71%
YTD Return 49.31%
Year Return 1.89%

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

Pixelworks, Inc. (NASDAQ:PXLW) Breaks Out?

Pixelworks, Inc. (NASDAQ:PXLW)

Pixelworks, Inc. (NASDAQ:PXLW) has performed well over the past quarter (+37.23%), year (+79.17%), and also YTD (+38.21%). Today volumes were strong and PXLW reached over the analyst’s consensus price target of $4.50. The average daily volume figure for PXLW is 339,500 but with almost an hour of trading left over 1.5 million shares had traded hands and PXLW had gained over 15%.

At the end of January, Pixelworks, Inc. (NASDAQ:PXLW) released their Q4 and full year financials. After that well received news, PXLW shares gained over 35% during the month of February. It is obvious that traders respond to news on PXLW shares which is what makes today’s price action curious. There is no news on the wires or chat boards.

The Average True Range (ATR) for PXLW is $0.21 which is expected given a stock with a price below $5. The ATR is used as a measure of a stock’s volatility and is a calculation based on the highs and lows a stock has reached over the trading day(s). Today the difference between the day’s high and low is $0.90 – more than four times the ATR.

Traders may be playing on the 52-week high figure which could represent a break-out. Prior to today’s trading shares of Pixelworks, Inc. (NASDAQ:PXLW) were less than 1% away. Some experts believe that traders are pushing the stock over that level to entice other traders, or trading programs, to recognize the price action breaking that high and buying into a momentum play. Volumes might point to some support for this – today’s volumes are over 5 ½ times the average daily volume.

3/8/2017
Ticker Symbol PXLW
Last Price a/o 3:31 PM EST  $                      4.44
Average Volume                    339,250
Market Cap (mlns)  $                  114.20
Sales (mlns) $53.40
Shares Outstanding (mlns) 29.51
Share Float (mlns) 23.71
Shortable Yes
Optionable Yes
Inside Ownership 3.00%
Short Float 3.50%
Short Interest Ratio 4.56
Quarterly Return 37.23%
YTD Return 38.21%
Year Return 79.17%

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

ParkerVision, Inc. (NASDAQ:PRKR) Again Prevails over Qualcomm (NASDAQ:QCOM)

ParkerVision, Inc. (NASDAQ:PRKR)

ParkerVision, Inc. (NASDAQ:PRKR) is experiencing massive volumes on the back of some favorable rulings by the Patent Trial and Appeal Board (“PTAB”). Average daily volume for PRKR is listed at 240,550 shares per day. However, just ten minutes into the trading session, already over 1.9 million shares have traded hands. PRKR shares ended yesterday at $2.59 and gapped on the open to $3.43 – an overnight gain of over 30%.

ParkerVision, Inc. (NASDAQ:PRKR) has been involved in several disputes surrounding patents with Qualcomm Inc. (NASDAQ:QCOM). Qualcomm has a market cap in excess of $84 billion. ParkerVision’s market cap is around $35 million. This morning, ParkerVision announced the PTAB’s latest decision with regard to the petitions for Inter Partes Review (“IPR”) filed by Qualcomm against ParkerVision patents. ParkerVision has now prevailed in over six out of the ten petitions originally filed – one decision resulted in a “split decision”. ParkerVision received early favorable rulings in March 2016 when the PTAB rejected Qualcomm’s request for institution on three IPR challenges to a ParkerVision patent. There are no more decisions in front of the PTAB challenging ParkerVision’s patents.

ParkerVision CEO Jeffrey Parker commented, “We continue to take positive steps forward in our Qualcomm proceedings and believe these results are indicative of the strength of ParkerVision’s innovations and our plan to realize the value of those assets, particularly in light of the high success rate of petitioners in invalidating patents through IPR challenges. We are pleased that the PTAB confirmed the validity of claims from both of the patents we chose to defend.”

ParkerVision, Inc. (NASDAQ:PRKR) designs, develops and markets its proprietary radio-frequency (RF) technologies that enable advanced wireless solutions for current and next generation communications networks. Protected by a worldwide patent portfolio, ParkerVision’s solutions for the wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with efficient power consumption.

Shares of ParkerVision, Inc. (NASDAQ:PRKR) are trading 88.6% above their 52-week low but are still 57.9% below their 52-week high. YTD shares of PRKR are up over 40%. These observations parallel the stock’s Relative Strength Index figure which is at 82.9 – a level often associated with an “over-bought” signal. Traders should take note the short float and short ratio figures below.

3/8/2017
Ticker Symbol PRKR
Last Price a/o 9:03 AM EST  $                      3.52
Average Volume                    240,550
Market Cap (mlns)  $                    34.65
Sales (mlns) $4.10
Shares Outstanding (mlns) 13.38
Share Float (mlns) 10.85
Shortable Yes
Optionable Yes
Inside Ownership 4.60%
Short Float 17.25%
Short Interest Ratio 7.78
Quarterly Return -0.38%
YTD Return 40.76%
Year Return 7.92%

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy. 

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading.

Traders Getting in Ahead of Turtle Beach Corp (NASDAQ:HEAR) Earnings Release

Turtle Beach Corp (NASDAQ:HEAR)

Turtle Beach Corp (NASDAQ:HEAR) is scheduled to release its Q4 and full year earnings tomorrow. But traders aren’t waiting and appear to be betting on a repeat of their last quarter of positive news.

Shares of Hear were trading thinly prior to noon EST then the price action exploded. The price shot up from $1.04 to $1.33 in an hour and a half. Currentl shares are up 25% on volumes that are over eight times their daily average. There is word of a ratings upgrade, however that was first reported prior to the market open. A review of trader chat rooms did not find any evidence that the earnings had been improperly disclosed prior to their announced release time tomorrow.

For Q3, Turtle Beach Corp (NASDAQ:HEAR) reported an EPS loss of $0.10 which was $0.06 better than analysts expected. Revenues came in at $38.38 million which beat street estimates by over $1 million.

San Diego, CA-based Turtle Beach Corp (NASDAQ:HEAR) designs audio products for the consumer, commercial and healthcare sectors. Products are sold in 27,000 storefronts globally across 44 countries. The company has more than 370,000 points of distribution. In addition, the company has installed more than 16,000 interactive point-of-sale displays at retailers globally.

Six firm follow Turtle Beach Corp (NASDAQ:HEAR). Three rate the shares as a “Strong Buy” while the other three rate shares of HEAR as a “Hold”. Their consensus price target is $1.45 – just $0.13 from current price levels. Shares are trading above their 50-day simple moving average (+3.38%) and their 200-day simple moving average (+8.88%).

3/7/2017
Ticker Symbol HEAR
Last Price a/o 1:43 PM EST  $                      1.30
Average Volume                    265,950
Market Cap (mlns)  $                    50.77
Sales (mlns) $176.30
Shares Outstanding (mlns) 48.82
Share Float (mlns) 22.2
Shortable Yes
Optionable No
Inside Ownership 10.50%
Short Float 3.14%
Short Interest Ratio 2.62
Quarterly Return -25.18%
YTD Return -20.61%
Year Return -7.14%

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance.

ViewRay, Inc. (Nasdaq:VRAY) Gets FDA Clearance

ViewRay, Inc. (Nasdaq:VRAY)

ViewRay, Inc. (Nasdaq:VRAY) is designs, develops, and markets radiation therapy systems globally. Today VRAY shares are up over 25% on news that the company has received clearance from the FDA for one of their product lines – Mridian Linac systems. Trading in VRAY is heavy – over 40 times its daily average.

The first two MRIdian Linac systems in the United States are expected to be installed at Henry Ford Hospital in Detroit and Barnes-Jewish Hospital at Washington University in St. Louis. Cleveland, OH-based ViewRay Inc. (NASDAQ:VRAY) considers MRIdian Linac to be the next-generation linear accelerator-based MRI-guided radiation therapy system.

Benjamin Movsas, M.D., chairman of Radiation Oncology at the Henry Ford Cancer Institute in Michigan, stated in a press release “Radiation oncologists have long awaited the availability of a clinical system that integrates MR-imaging with linac radiation delivery, as this is a major breakthrough in improving the efficacy of radiation therapy for patients.”

With MRI-guided radiation therapy, we’re able to watch the movement of tumors and organs in the body as radiation is being delivered and adapt the dose of radiation in real-time, to help ensure the maximum dose reaches the tumor and that surrounding healthy tissue is spared,” said Sasa Mutic, Ph.D., director of Radiation Oncology Physics at Washington University School of Medicine. “This technology helps us treat tumors such those in the lung, liver and pancreas where increased precision is important due to nearby organs and other critical structures.”

In January, Puissance Capital Management led a $26.1 million (before expenses) private placement financing round that included common stock and warrants. Puissance Capital was joined by some of ViewRay’s existing investors, including OrbiMed Advisors, LLC and Kearny Venture Partners, and an additional new institutional investor, Acuta Capital Partners. ViewRay Inc. (NASDAQ:VRAY) sold approximately 8.6 million shares of common stock and warrants to purchase approximately 1.7 million shares of common stock.

ViewRay Inc. (NASDAQ:VRAY) has an impressive sales track record. In 2012 ViewRay reported sales of $1.9 million and in 2015 that number jumped to $10.4 million. EPS for shareholders has gone the other direction. A loss of $0.66 EPS has continued to widen and in 2015 the EPS loss was $1.18. Two firms follow ViewRay Inc. (NASDAQ:VRAY) and both rate VRAY shares as a “Strong Buy”.

 

2/27/2017
Ticker Symbol VRAY
Last Price a/o 1:55 PM EST  $                      6.03
Average Volume                      95,300
Market Cap (mlns)  $                  206.49
Sales (mlns) $10.70
Shares Outstanding (mlns) 43.38
Share Float (mlns) 37.36
Shortable Yes
Optionable No
Inside Ownership 2.20%
Short Float 1.49%
Short Interest Ratio 5.82
Quarterly Return 50.16%
YTD Return 52.08%
Year Return 0.00%

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20 year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

 

Seanergy Maritime Holdings Corp. (NASDAQ:SHIP)

Delta Technology Holdings (Nasdaq: DELT) Doubles on Sales Figures

Delta Technologies Holdings Limited – Nasdaq: DELT 

China-based Delta Technology Holdings shares doubled in trading yesterday. The shares, traded on the Nasdaq under ticker DELT, benefitted from news that its Q4 sales doubled from the previous year’s Q4 figures. DELT closed Wednesday at $0.86 and rocketed to $2.28 before ending the day at $1.70 on exceptionally heavy volumes. Traders should take note that the financial reports peg the USD/RMB exchange rate at 1:6.85. 

Delta went public on the Nasdaq in 2014. Delta Technology Holdings Limited manufactures and sells fine and specialty chemicals in the People’s Republic of China utilizing green technologies. Delta Technologies provides specialty chemical products to more than 380 clients around the world. The company provides its products for automotive, pharmaceutical, agrochemical, dye and pigments, aerospace, ceramics, coating-printing, clean energy, and food additive applications.  

DELT EPS have been inconsistent since 2013 (-$2.21) with positive EPS in 2014 ($0.17) and 2015 ($0.22) but negative reported EPS in 2016 (-$0.73). DELT reported sales peaked in 2015 with $202 million in reported sales but fell to $53.4 million in 2016. Delta Technology Holdings is not followed by any firms. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/19/2017
Ticker Symbol DELT
Last Price a/o 4:00 PM EST  $                      1.70
Average Volume 420,000
Market Cap 14.5 million
Sales $53.4 million
Shares Outstanding 8.55 million
Share Float 3 million
Shortable Yes
Optionable No
Inside Ownership
Short Float 0.19%
Short Interest Ratio 0.01
Quarterly Return 44.94%
YTD Return 132.30%
Year Return 58.49%

Top 10 Nasdaq Sm Cap Shorted Shares – Ending Jan 13, 2017

Week Ending 1/13/2017 – Most Shorted Nasdaq Small Caps

“Float” – Floating stock is calculated by subtracting closely-held shares and restricted stock from a firm’s total outstanding shares.

“Short Float” – the number of shorted shares divided by the number of floating shares.

“Short Ratio” – the number of shares that have been sold short and not yet covered – typically expressed as a percentage of the average daily trading volume.